Jill Carey Hall, BofA Global Research head of U.S. small/mid cap strategy, joins CNBC's 'Squawk Box' to discuss outlooks on ...
BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...
The U.S. stock market is back to an uncomfortably familiar spot, with Wall Street no longer celebrating good news on the ...
Stock investors may start shunning favorable economic data, Bank of America said ahead of Friday’s release of the December ...
International benchmark Brent crude will average $65 a barrel this year as new oil production from non-OPEC countries ...
Electric utilities that can increase earnings related to data center energy demand should see their share prices rise in 2025 ...
Manufacturing activity could begin to expand as soon as April of this year, Bank of America strategists said in a recent note ...
Texas and other GOP-led states have taken aim at Wall Street for practices they view as hostile to fossil fuels, and ...
BofA analyst Alec Stranahan lowered the firm’s price target on Regenxbio (RGNX) to $22 from $25 and keeps a Buy rating on the ...
U.S. banks Citigroup and Bank of America said on Tuesday they are exiting the Net-Zero Banking Alliance (NZBA), a group of ...
Regarding monetary policy, BofA commented that the Central Bank of the Republic of Turkiye (CBRT) should continue its ...
BofA Securities published its Growth 10 list for January 2025, as investors in the U.S. equity market seek to build on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback